Howard L. Kaufman, MD, FACS | Authors


From the Editor: Is Cancer a Curable Disease?

July 14, 2016

After just returning from the 2016 American Society of Clinical Oncology meeting in Chicago, it was clear that there is a palpable excitement over recent progress in cancer research and therapeutic drug development.

From the Editor: Exciting Advancements in Therapeutic Regimens

July 08, 2016

Advances in the treatment of cancer have been possible due to the use of agents that target genomic mutations involving oncogenic signaling and immune regulatory pathways. These advances have resulted in major paradigm shifts in our clinical approach to the patient with metastatic cancer.